Dagfinn Steinar Øgreid • 1956 • Sandnes • 15 roles • 11 shareholdings

This website uses cookies to enhance the user experience.

Roles

Management

Name	Role	Total operating income	Total equity	Shares
L LIMONA AS	Managing Director/CEO	300,000	105,147	100 % indirectly
F FLOKKI AS	Managing Director/CEO	377,729	410,035	48.76 % indirectly
C COLOALERT AS	Managing Director/CEO	-	5,762,141	33.33 % indirectly
U UNI TARGETING RESEARCH AS	Managing Director/CEO	19,212,741	22,847,691	31.3 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
L LIMONA AS	Chairman	300,000	105,147	100 % indirectly
C CITRON AS	Contact Person	192,000	10,940,364	100 % directly
F FLOKKI AS	Chairman	377,729	410,035	48.76 % indirectly
C COLOALERT AS	Board Member	-	5,762,141	33.33 % indirectly
M MOSAIC ONCOLOGY AS	Chairman	30,840	-4,976	33.33 % indirectly
U UNI TARGETING RESEARCH AS	Chairman	19,212,741	22,847,691	31.3 % indirectly
E EUROPEAN ONCOLOGY LAB AS	Board Member	-	-8,926	31.3 % indirectly
N NORDIC DIAGNOSTICS AS	Chairman	-	29,004	30 % indirectly
K KOLIBRI MEDICAL GROUP AS	Contact Person	-	-44,335,703	5 % indirectly
N NORDISK FEDERASJON FOR MEDISINSK UNDERVISNING (NFMU)	Chairman	-	-	-

Last update: Feb 27, 2025

Shares owned by Dagfinn Steinar Øgreid

Name	Share class	Total operating income	Total equity	Share
C CITRON AS	Ordinære aksjer	192,000	10,940,364	100 % directly
L LIMONA AS		300,000	105,147	100 % indirectly
F FLOKKI AS		377,729	410,035	48.76 % indirectly
C COLOALERT AS		0	5,762,141	33.33 % indirectly
M MOSAIC ONCOLOGY AS		30,840	-4,976	33.33 % indirectly
E EUROPEAN ONCOLOGY LAB AS		0	-8,926	31.3 % indirectly
U UNI TARGETING RESEARCH AS		19,212,741	22,847,691	31.3 % indirectly
N NORDIC DIAGNOSTICS AS		0	29,004	30 % indirectly
K KOLIBRI MEDICAL GROUP AS		0	-44,335,703	5 % indirectly
L LEGELISTEN.NO AS		1,395,291	829,736	4.14 % indirectly
D DR. DROPIN HUD COCO AS		0	20,026,573	3.22 % indirectly

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025